Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8866917rdf:typepubmed:Citationlld:pubmed
pubmed-article:8866917lifeskim:mentionsumls-concept:C0013227lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C0026030lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C0085149lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:8866917lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:8866917pubmed:issue3lld:pubmed
pubmed-article:8866917pubmed:dateCreated1996-12-13lld:pubmed
pubmed-article:8866917pubmed:abstractText1. Tacrolimus, an immunosuppressive macrolide, is metabolized by enzymes of the cytochrome P450 3A subfamily. In this study, 34 drugs were tested for their interactions with tacrolimus metabolism by human liver microsomes. 2. Fifteen drugs which inhibit the in vitro metabolism of tacrolimus were identified: bromocriptine, corticosterone, dexamethasone, ergotamine, erythromycin, ethinyloestradiol, josamycin, ketoconazole, miconazole, midazolam, nifedipine, omeprazole, tamoxifen, troleandomycin and verapamil.lld:pubmed
pubmed-article:8866917pubmed:languageenglld:pubmed
pubmed-article:8866917pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8866917pubmed:citationSubsetIMlld:pubmed
pubmed-article:8866917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8866917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8866917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8866917pubmed:statusMEDLINElld:pubmed
pubmed-article:8866917pubmed:monthMarlld:pubmed
pubmed-article:8866917pubmed:issn0306-5251lld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:SewingK FKFlld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:SchmidtGGlld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:BaderAAlld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:ChristiansUUlld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:LinckAAlld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:SchottmannRRlld:pubmed
pubmed-article:8866917pubmed:authorpubmed-author:LampenAAlld:pubmed
pubmed-article:8866917pubmed:issnTypePrintlld:pubmed
pubmed-article:8866917pubmed:volume41lld:pubmed
pubmed-article:8866917pubmed:ownerNLMlld:pubmed
pubmed-article:8866917pubmed:authorsCompleteYlld:pubmed
pubmed-article:8866917pubmed:pagination187-90lld:pubmed
pubmed-article:8866917pubmed:dateRevised2009-10-2lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:meshHeadingpubmed-meshheading:8866917-...lld:pubmed
pubmed-article:8866917pubmed:year1996lld:pubmed
pubmed-article:8866917pubmed:articleTitleIdentification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes.lld:pubmed
pubmed-article:8866917pubmed:affiliationInstitut für Allgemeine Pharmakologie, Medizinische Hochschule Hannover, Germany.lld:pubmed
pubmed-article:8866917pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8866917pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8866917pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8866917lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8866917lld:pubmed